Company Eurofins Cerep

Equities

ALECR

FR0013256518

Biotechnology & Medical Research

Real-time Euronext Paris 08:00:01 15/04/2024 pm IST 5-day change 1st Jan Change
21,800 EUR -0.91% Intraday chart for Eurofins Cerep 0.00% -12.80%

Business Summary

Eurofins Cerep (formerly Eurofins-Cerep) specializes in the pre-clinical research of drugs for the pharmaceutical industry.

Exports account for 97.9% of net sales.

Number of employees: 209

Sales per Business

EUR in Million2021Weight2022Weight Delta
Preclinical Drug Research Services
100.0 %
42 100.0 % 48 100.0 % +14.45%

Sales per region

EUR in Million2021Weight2022Weight Delta
International
97.7 %
38 90.9 % 47 97.7 % +23.05%
France
2.3 %
4 9.1 % 1 2.3 % -71.19%

Managers

Managers TitleAgeSince
Chief Executive Officer - 19/18/19
Chairman - 13/14/13

Members of the board

Members of the board TitleAgeSince
Chairman - 13/14/13
Director/Board Member 68 10/15/10
Chief Executive Officer - 19/18/19

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 5,044 213 ( 4.223 %) 0 4.223 %

Shareholders

NameEquities%Valuation
4,831 95.76 % 120 M €

Company contact information

Eurofins-Cerep SA

Le bois l'Evêque

86600, Celle l'Evescault

+33 5 49 89 30 00

http://www.eurofins.fr/cerep/
address Eurofins Cerep(ALECR)
  1. Stock Market
  2. Equities
  3. ALECR Stock
  4. Company Eurofins Cerep